State Street
PRCT icon

State Street’s Procept Biorobotics PRCT Stock Holding History

State Street’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$36.5M Buy
1,617,475
+87,844
+6% +$2.2M ﹤0.01% 2039
2026
Q1 		$38.3M Buy
1,529,631
+40,602
+3% +$1.14M ﹤0.01% 1890
2025
Q4 		$46.8M Buy
1,489,029
+164,358
+12% +$5.45M ﹤0.01% 1775
2025
Q3 		$47.3M Buy
1,324,671
+55,561
+4% +$2.54M ﹤0.01% 1749
2025
Q2 		$73.1M Buy
1,269,110
+81,849
+7% +$4.63M ﹤0.01% 1472
2025
Q1 		$69.2M Sell
1,187,261
-1,438
-0.1% -$98.2K ﹤0.01% 1476
2024
Q4 		$95.7M Buy
1,188,699
+9,185
+0.8% +$785K ﹤0.01% 1363
2024
Q3 		$94.5M Buy
1,179,514
+66,175
+6% +$4.7M ﹤0.01% 1355
2024
Q2 		$68M Buy
1,113,339
+45,837
+4% +$2.73M ﹤0.01% 1500
2024
Q1 		$52.8M Sell
1,067,502
-18,063
-2% -$860K ﹤0.01% 1698
2023
Q4 		$45.5M Buy
1,085,565
+53,854
+5% +$1.83M ﹤0.01% 1750
2023
Q3 		$33.9M Sell
1,031,711
-31,019
-3% -$1.06M ﹤0.01% 1845
2023
Q2 		$37.6M Buy
1,062,730
+265,072
+33% +$8.76M ﹤0.01% 1844
2023
Q1 		$22.7M Buy
797,658
+89,586
+13% +$3.16M ﹤0.01% 2141
2022
Q4 		$29.4M Buy
708,072
+45,510
+7% +$1.95M ﹤0.01% 1973
2022
Q3 		$27.5M Buy
662,562
+207,804
+46% +$8.29M ﹤0.01% 1997
2022
Q2 		$14.9M Buy
454,758
+340,596
+298% +$12.4M ﹤0.01% 2452
2022
Q1 		$4M Buy
114,162
+29,364
+35% +$707K ﹤0.01% 3291
2021
Q4 		$2.12M Buy
+84,798
New +$3.14M ﹤0.01% 3616

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

State Street's PRCT Position: Q2 2026 in Review

State Street increased its Procept Biorobotics (PRCT) stake by 5.7% in Q2 2026, buying an estimated $2.2M and bringing the position to 1,617,475 shares worth $36.5M. The position accounts for ﹤0.01% of the portfolio, ranked #2039.

State Street first reported a position in PRCT in Q4 2021 and has held it in 19 quarters since. The position peaked at $95.7M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • State Street held 1,617,475 shares of Procept Biorobotics worth $36.5M as of Q2 2026.
  • State Street bought 87,844 Procept Biorobotics shares in Q2 2026, an estimated $2.2M.
  • Procept Biorobotics made up ﹤0.01% of State Street's portfolio in Q2 2026, its #2039 holding.
  • State Street first reported a position in Procept Biorobotics in Q4 2021 and has held it in 19 quarters since.
  • State Street's Procept Biorobotics position peaked at $95.7M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on State Street's 13F filing for Q2 2026, filed 7 Aug 2026.